Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Other Operating Expenses (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Other Operating Expenses for 6 consecutive years, with $341.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 12.41% year-over-year to $341.2 million, compared with a TTM value of $649.1 million through Dec 2025, up 113.58%, and an annual FY2025 reading of $911000.0, down 96.75% over the prior year.
  • Other Operating Expenses was $341.2 million for Q4 2025 at Roivant Sciences, up from $307.8 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $341.2 million in Q4 2025 and bottomed at -$15.4 million in Q4 2023.
  • Average Other Operating Expenses over 5 years is $98.4 million, with a median of $1.7 million recorded in 2022.
  • The sharpest move saw Other Operating Expenses plummeted 99.81% in 2024, then skyrocketed 131440.17% in 2025.
  • Year by year, Other Operating Expenses stood at $853000.0 in 2021, then surged by 102.34% to $1.7 million in 2022, then crashed by 990.61% to -$15.4 million in 2023, then soared by 2074.23% to $303.5 million in 2024, then increased by 12.41% to $341.2 million in 2025.
  • Business Quant data shows Other Operating Expenses for ROIV at $341.2 million in Q4 2025, $307.8 million in Q3 2025, and $154000.0 in Q2 2025.